ESG

As Boise State prepares for the Pac-12, a new partnership reveals how data analytics is becoming the ultimate playbook for modern college athletics.

Growth equity firm SEMCAP launches a new fund with Unilever Prestige visionary Vasiliki Petrou, targeting the booming wellness and longevity market.

Early data for VG801 shows vision improvement in Stargardt disease patients, leveraging novel tech and fast-track FDA support to tackle a leading cause of blindness.

A pioneering lab is now using AI to improve diagnostic accuracy for complex prostate procedures, marking a major leap for AI in routine patient care.

A record number of journalists are finalists for Canada's top mental health reporting awards, reflecting a deeper media focus on addiction and wellness.

A new FDA-cleared device uses water vapor to ablate prostate tissue, showing high efficacy in trials while minimizing life-altering side effects.

Fraud losses are soaring as AI-powered scams get smarter. A new wave of defensive AI is fighting back to protect your digital life from deepfakes and fraud.

Riding high on record 2025 results and a new FDA approval, LivaNova faces intense scrutiny ahead of its May 6 earnings call. Can it sustain the momentum?

With cash dwindling and no FDA approval, ENDRA is exploring a sale. Will its innovative TAEUS® liver scanner find a champion or fade into obscurity?

A new study reveals Kansas City University's $498.9M annual economic impact, fueling jobs and tackling critical physician shortages across the Midwest.

SWBC's move to INTX's modern platform signals a major industry trend, replacing outdated systems to boost efficiency, governance, and scalability.

A unique partnership between a debt acquirer and a top charity is pushing for major UK financial inclusion reform from within the House of Lords.

With CE Mark approval, Countable Labs brings single-molecule counting PCR to Europe, promising unprecedented precision for gene therapy and diagnostics.

With €10M in new funding, Berlin-based Cellbricks is moving its biofabricated human tissues from lab to preclinical trials, promising a new era for patients.

Following a 40-year career shaping biotech finance, Jessica Chutter's move to PTC's board signals major strategic ambitions for the rare disease firm.

Bunzl Canada has appointed the world's first in-house cleaning verification experts, a move set to redefine sustainability and compliance in the industry.

A new NIH-funded study reveals that while Medicare covers acupuncture for back pain, federal rules create vast "care deserts" for seniors seeking relief.

Swedish biotech VERIGRAFT begins a pivotal trial for a personalized, lab-grown vein, offering hope for a true cure for millions with chronic venous insufficiency.

From the heart of Arabia, AlUla Peregrina brings a patented active to the global stage, promising scientifically-backed, ethical longevity beauty.

Firms invest heavily in fleet tech, yet equipment sits idle 50% of the time. A new report reveals a costly gap between digital adoption and real-world use.